Showing 3981-3990 of 9943 results for "".
- Real Housewife Gets Real About Self-Care, Coolsculptinghttps://practicaldermatology.com/news/real-housewife-gets-real-about-self-care-coolsculpting/2459938/Bravo's "The Real Housewives of New York City” Sonja Morgan is the face of Coolscuplting’s new "Let's Get Real About Self-Care" campaign. Morgan joins CoolSculpting in its mission to encourage women across the country by moving self-care to the top of th
- Inaugural World Eczema Day: GlobalSkin Launches International Movement for Eczema Sufferershttps://practicaldermatology.com/news/inaugural-world-eczema-day-globalskin-launches-international-movement-for-eczema-sufferers/2457611/To mark the first-ever Atopic Eczema Day, the International Alliance of Dermatology Patient Organizations (IADPO – also known as GlobalSkin) has launched AltogetherEczema, a new movement to elevate the urgent and unmet needs of the global eczema and atopic dermatitis community.
- ACR Update: TAK-279 Shows Promise in Phase 2b Psoriatic Arthritis Studyhttps://practicaldermatology.com/news/acr-update-tak-279-shows-promise-in-phase-2b-psoriatic-arthritis-study/2462119/Takeda's investigational tyrosine kinase 2 (TYK2) inhibitor TAK-279 showed significant efficacy in patients with active psoriatic arthritis, according to Phase 2b data slated to be presented at the American College of Rheumatology's (ACR) annual meeting in San Diego, California.
- Study Validates Long-Term Safety of Delgocitinib Cream in Adults With Chronic Hand Eczemahttps://practicaldermatology.com/news/study-validates-long-term-safety-of-delgocitinib-cream-in-adults-chronic-hand-eczema/2462105/LEO Pharma’s Delgocitinib Cream was well-tolerated in adults with moderate to severe chronic hand eczema (CHE), according to results from the DELTA 3 Open-Label Extension Trial. What’s more, patients who entered the DELTA 3 trial after receiving delgocitinib cream
- ICYMI: Vaseline, CVS Partner to Bridge the Gap of Skin Care Inequities in People of Colorhttps://practicaldermatology.com/news/icymi-vaseline-cvs-partner-to-bridge-the-gap-of-skin-care-inequities-in-people-of-color/2461988/Vaseline’s recent Train the Trainer webinar helped educate CVS field leaders on the skin care inequities that exist for Black and Brown populations as part of the brand’s ongoing partnership with CVS Health. During the webcast, Boston area-based dermatologi
- Dan Walker Named VP of US Commercial Operations at SciBasehttps://practicaldermatology.com/news/dan-walker-named-vp-of-us-commercial-operations-at-scibase/2461977/Dan Walker is SciBase’s new VP of US Commercial Operations. SciBase's products include Nevisense and Nevisense Go which address melanoma detection, non-melanoma skin cancer detection, and skin barrier assessment. Mr. Walker was previously Senior Dire
- New CEO for SciBasehttps://practicaldermatology.com/news/new-ceo-for-scibase/2461967/Pia Renaudin is SciBase’s new Chief Executive Officer (CEO), effective October 1st, 2023. SciBase's products include Nevisense and Nevisense Go and address melanoma detection, non-melanoma skin cancer detection and skin barrier assessment. Ms.
- Verrica Supports FDA’s Warning Letters to Retailers Selling Unapproved Molluscum Contagiosum Treatmentshttps://practicaldermatology.com/news/verrica-supports-fdas-warning-letters-to-retailers-selling-unapproved-molluscum-contagiosum-treatments/2461954/Verrica Pharmaceuticals Inc. supports the U.S. Food and Drug Administration’s (FDA’s) recent action against retailers and manufacturers of unapproved products for the treatment of molluscum contagiosum. “On the heels of the June 1, 2023 FDA warning to consumers not to
- Spotlight on the Skin of Color Societyhttps://practicaldermatology.com/news/spotlight-on-the-skin-of-color-society/2461823/It’s almost the Skin of Color Society’s (SOCS) 20th anniversary, and the group will be celebrating with several signature programs and new initiatives aimed at bringing greater diversity to dermatology, reducing healthcare disparities, advancing research, expanding training and m
- Dr. Neil Shah Named New KOL for LASEROPTEK Co. Ltd.https://practicaldermatology.com/news/dr-neil-shah-named-new-kol-for-laseroptek-co-ltd/2461797/Neil Shah, MD, is now a national key opinion leader (KOL) for LASEROPTEK's PALLAS UVB laser system for inflammatory skin conditions. LASEROPTEK's PALLAS laser system is a UVB laser that is US Food and Drug Administration (FDA) -cleared to treat inflammatory skin condit